drugset / Trial / NCT04072562
A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the relative bioavailability of the AZD7594 nebulized formulations (test) and the dry powder formulation (reference). The study results will provide information on the pharmacokinetic (PK) profile following use of the 2 devices to be used in further clinical development.
Timeline
- Start
- 2019-09-19
- Primary completion
- 2019-11-28
- Completion
- 2019-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VELSECORAT | Other / unclassified | 0.7 mg | Inhaled |
| Subject | VELSECORAT | Other / unclassified | 720 ug | Inhaled |
| Subject | VELSECORAT | Other / unclassified | 1.6 mg | Inhaled |